Dongguan Wangshun Biotechnology Co., Ltd. announced that it has entered into capital increase agreement and will receive CNY 16.50 million in a round of funding on March 22, 2022. The transaction will include participation from Nanjing Julong Science&Technology Co.,LTD for 55% stake. The transaction has been approved in the 6th session of the company's 5th directorate and the 6th session of the company's 5th supervisory board approved.

The registered capital will increase from CNY 5 million to CNY 30 million.